Matthew G Johnson
Overview
Explore the profile of Matthew G Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
2613
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caraco Y, Johnson M, Chiarappa J, Maas B, Stone J, Rizk M, et al.
Clin Trials
. 2025 Mar;
:17407745251313925.
PMID: 40025641
Background: Pre-specified interim analyses allow for more timely evaluation of efficacy or futility, potentially accelerating decision-making on an investigational intervention. In such an analysis, the randomized, double-blind MOVe-OUT trial demonstrated...
2.
Swift M, Breeher L, Dierkhising R, Hickman J, Johnson M, Roellinger D, et al.
Open Forum Infect Dis
. 2024 Sep;
11(9):ofae495.
PMID: 39290777
Background: Uncertainty exists regarding the effectiveness of COVID-19 vaccine to prevent postacute sequelae of COVID-19 (PASC) following a breakthrough infection. While most studies based on symptom surveys found an association...
3.
Pokorny L, Pellicer J, Woudstra Y, Christenhusz M, Garnatje T, Palazzesi L, et al.
Front Plant Sci
. 2024 Jul;
15:1340056.
PMID: 38947944
Reconstructing evolutionary trajectories and transitions that have shaped floral diversity relies heavily on the phylogenetic framework on which traits are modelled. In this study, we focus on the angiosperm order...
4.
Strizki J, Grobler J, Murgolo N, Fridman A, Johnson M, Du J, et al.
Infect Dis Ther
. 2024 Apr;
13(5):1159-1160.
PMID: 38662333
No abstract available.
5.
Zuntini A, Carruthers T, Maurin O, Bailey P, Leempoel K, Brewer G, et al.
Nature
. 2024 Apr;
629(8013):843-850.
PMID: 38658746
Angiosperms are the cornerstone of most terrestrial ecosystems and human livelihoods. A robust understanding of angiosperm evolution is required to explain their rise to ecological dominance. So far, the angiosperm...
6.
Maas B, Strizki J, Miller R, Kumar S, Brown M, Johnson M, et al.
Clin Transl Sci
. 2024 Apr;
17(2):e13732.
PMID: 38593352
Molnupiravir is an oral prodrug of the broadly active, antiviral ribonucleoside analog N-hydroxycytidine (NHC). The primary circulating metabolite NHC is taken up into cells and phosphorylated to NHC-triphosphate (NHC-TP). NHC-TP...
7.
Caraco Y, Crofoot G, Moncada P, Galustyan A, Musungaie D, Payne B, et al.
NEJM Evid
. 2024 Feb;
1(2):EVIDoa2100043.
PMID: 38319179
BACKGROUND: Safe and effective oral treatments are needed to improve clinical outcomes for nonhospitalized patients with Covid-19. Molnupiravir is an orally administered, small-molecule ribonucleoside prodrug shown to inhibit replication of...
8.
Johnson M, Strizki J, Jensen E, Cohen J, Katlama C, Fishchuk R, et al.
Microbiol Spectr
. 2024 Feb;
12(3):e0356323.
PMID: 38299867
Importance: Respiratory viral coinfections are known to occur with coronavirus disease-2019 (COVID-19). In a cohort of non-hospitalized adults with mild-to-moderate COVID-19 treated with molnupiravir versus placebo in the MOVe-OUT trial...
9.
Strizki J, Grobler J, Murgolo N, Fridman A, Johnson M, Du J, et al.
Infect Dis Ther
. 2023 Nov;
12(12):2725-2743.
PMID: 37995070
Introduction: The randomized, placebo-controlled, double-blind MOVe-OUT trial demonstrated molnupiravir (800 mg every 12 h for 5 days) as safe and effective for outpatient treatment of mild-to-moderate COVID-19, significantly reducing the...
10.
Overson R, Johnson M, Bechen L, Kinosian S, Douglas N, Fant J, et al.
BMC Ecol Evol
. 2023 Nov;
23(1):66.
PMID: 37974080
Background: The evening primrose family (Onagraceae) includes 664 species (803 taxa) with a center of diversity in the Americas, especially western North America. Ongoing research in Onagraceae includes exploring striking...